Q4 2014

Filed Mar 24, 2015 · 10-K · 83 days after period end · 0001615219-15-000004

Q4 2014 · 10-K

Revenue—

Net Income

-$3.74M

no prior Q4 2013 on file

EPS Diluted

-$1.82

no prior Q4 2013 on file

Same quarter

no prior Q4 2013 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Dec 31, 2014 · filed Mar 24, 2015 · 83 d after period end

Decoy Therapeutics Inc. · CIK 1615219 · Engraved from SEC EDGAR